Filed: 11/14/2024ACC: 0001104659-24-118975
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $43.66M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$43.66M
Total AUM (reported)
9.41M
Total Shares
Allocation by class
COM$43.66M100.0%
Portfolio Concentration
Top 3$43.66M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.41M
Sole
Full voting authority
9.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
KYVERNA THERAPEUTICS INC
SOLEShares3.26M
TypeSH
Market value$15.92M
36.46%
Sole
3.26M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$14.33M
32.82%
Sole
4.21M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$13.41M
30.72%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KYVERNA THERAPEUTICS INCSOLE | COM | 3.26M | SH | $15.92M 36.46% | 3.26M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $14.33M 32.82% | 4.21M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $13.41M 30.72% | 1.94M | 0.00 | 0.00 |